Furthermore the diversity of mutations that occur in ALS, and the involvement of disparate genetic lesions in other loci, suggests that ALS is likely not a single homogenous disease and SOD1 might behave with different kinetics in each instance. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.